These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19646406)

  • 41. Attenuated Human Parainfluenza Virus Type 1 (HPIV1) Expressing the Fusion Glycoprotein of Human Respiratory Syncytial Virus (RSV) as a Bivalent HPIV1/RSV Vaccine.
    Mackow N; Amaro-Carambot E; Liang B; Surman S; Lingemann M; Yang L; Collins PL; Munir S
    J Virol; 2015 Oct; 89(20):10319-32. PubMed ID: 26223633
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intranasal immunization with a helper-dependent adenoviral vector expressing the codon-optimized fusion glycoprotein of human respiratory syncytial virus elicits protective immunity in BALB/c mice.
    Fu YH; He JS; Qiao W; Jiao YY; Hua Y; Zhang Y; Peng XL; Hong T
    Virol J; 2013 Jun; 10():183. PubMed ID: 23742026
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Attenuated temperature-sensitive respiratory syncytial virus mutants generated by cold adaptation.
    Randolph VB; Kandis M; Stemler-Higgins P; Kennelly MS; McMullen YM; Speelman DJ; Weeks-Levy C
    Virus Res; 1994 Sep; 33(3):241-59. PubMed ID: 7985411
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The non-structural proteins of RSV: targeting interferon antagonists for vaccine development.
    Teng MN
    Infect Disord Drug Targets; 2012 Apr; 12(2):129-37. PubMed ID: 22335499
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhanced Neutralizing Antibody Response Induced by Respiratory Syncytial Virus Prefusion F Protein Expressed by a Vaccine Candidate.
    Liang B; Surman S; Amaro-Carambot E; Kabatova B; Mackow N; Lingemann M; Yang L; McLellan JS; Graham BS; Kwong PD; Schaap-Nutt A; Collins PL; Munir S
    J Virol; 2015 Sep; 89(18):9499-510. PubMed ID: 26157122
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of recombinant respiratory syncytial virus gene deletion mutants in African green monkeys for their potential as live attenuated vaccine candidates.
    Jin H; Cheng X; Traina-Dorge VL; Park HJ; Zhou H; Soike K; Kemble G
    Vaccine; 2003 Sep; 21(25-26):3647-52. PubMed ID: 12922094
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge.
    Wang D; Phan S; DiStefano DJ; Citron MP; Callahan CL; Indrawati L; Dubey SA; Heidecker GJ; Govindarajan D; Liang X; He B; Espeseth AS
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28298602
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3.
    Schmidt AC; McAuliffe JM; Murphy BR; Collins PL
    J Virol; 2001 May; 75(10):4594-603. PubMed ID: 11312329
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of mutations contributing to the temperature-sensitive, cold-adapted, and attenuation phenotypes of the live-attenuated cold-passage 45 (cp45) human parainfluenza virus 3 candidate vaccine.
    Skiadopoulos MH; Surman S; Tatem JM; Paschalis M; Wu SL; Udem SA; Durbin AP; Collins PL; Murphy BR
    J Virol; 1999 Feb; 73(2):1374-81. PubMed ID: 9882342
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acquisition of the ts phenotype by a chemically mutagenized cold-passaged human respiratory syncytial virus vaccine candidate results from the acquisition of a single mutation in the polymerase (L) gene.
    Crowe JE; Firestone CY; Whitehead SS; Collins PL; Murphy BR
    Virus Genes; 1996; 13(3):269-73. PubMed ID: 9035372
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Attenuation of live respiratory syncytial virus vaccines is associated with reductions in levels of nasal cytokines.
    Karron RA; Thumar B; Schappell E; Buchholz UJ; Collins PL
    J Infect Dis; 2013 Jun; 207(11):1773-9. PubMed ID: 23482643
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nucleotide sequence analysis of the respiratory syncytial virus subgroup A cold-passaged (cp) temperature sensitive (ts) cpts-248/404 live attenuated virus vaccine candidate.
    Firestone CY; Whitehead SS; Collins PL; Murphy BR; Crowe JE
    Virology; 1996 Nov; 225(2):419-22. PubMed ID: 8918930
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Three amino acid substitutions in the L protein of the human parainfluenza virus type 3 cp45 live attenuated vaccine candidate contribute to its temperature-sensitive and attenuation phenotypes.
    Skiadopoulos MH; Durbin AP; Tatem JM; Wu SL; Paschalis M; Tao T; Collins PL; Murphy BR
    J Virol; 1998 Mar; 72(3):1762-8. PubMed ID: 9499025
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Creation of matrix protein gene variants of two serotypes of vesicular stomatitis virus as prime-boost vaccine vectors.
    Kim GN; Wu K; Hong JP; Awamleh Z; Kang CY
    J Virol; 2015 Jun; 89(12):6338-51. PubMed ID: 25855732
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Respiratory Syncytial Virus Attachment Gene Variant Associated with More Severe Disease in Infants Decreases Fusion Protein Expression, Which May Facilitate Immune Evasion.
    Human S; Hotard AL; Rostad CA; Lee S; McCormick L; Larkin EK; Peret TCT; Jorba J; Lanzone J; Gebretsadik T; Williams JV; Bloodworth M; Stier M; Carroll K; Peebles RS; Anderson LJ; Hartert TV; Moore ML
    J Virol; 2020 Dec; 95(2):. PubMed ID: 33115881
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Antibody responses induced by mucosal DNA vaccine encoding the codon-optimized F protein of human respiratory syncytial virus (RSV) delivered with attenuated Salmonella typhimurium].
    Cheng M; He J; Fu Y; Qiao W; Jiao Y
    Wei Sheng Wu Xue Bao; 2011 Jul; 51(7):965-71. PubMed ID: 22043798
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Optimization of the Codon Pair Usage of Human Respiratory Syncytial Virus Paradoxically Resulted in Reduced Viral Replication
    Le Nouën C; Luongo CL; Yang L; Mueller S; Wimmer E; DiNapoli JM; Collins PL; Buchholz UJ
    J Virol; 2020 Jan; 94(2):. PubMed ID: 31666376
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Generation of recombinant human parainfluenza virus type 1 vaccine candidates by importation of temperature-sensitive and attenuating mutations from heterologous paramyxoviruses.
    Newman JT; Riggs JM; Surman SR; McAuliffe JM; Mulaikal TA; Collins PL; Murphy BR; Skiadopoulos MH
    J Virol; 2004 Feb; 78(4):2017-28. PubMed ID: 14747566
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mucosal Delivery of Recombinant Vesicular Stomatitis Virus Vectors Expressing Envelope Proteins of Respiratory Syncytial Virus Induces Protective Immunity in Cotton Rats.
    Binjawadagi B; Ma Y; Binjawadagi R; Brakel K; Harder O; Peeples M; Li J; Niewiesk S
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33408176
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Codon Deletions in the Influenza A Virus PA Gene Generate Temperature-Sensitive Viruses.
    Meyer L; Sausset A; Sedano L; Da Costa B; Le Goffic R; Delmas B
    J Virol; 2016 Jan; 90(7):3684-93. PubMed ID: 26792748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.